Oscar Health (OSCR) ebitda was -$267M in FY2025 (-228% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
-$267M
-228%
2024
$208M
+647%
2023
-$38M
+92%
2022
-$462M
-4%
2021
-$444M
-25%
2020
-$355M
-62%
2019
-$219M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$415M
Q1 2026
$727M
Q4 2025
-$295M
Q3 2025
-$101M
Q2 2025
-$199M
Q1 2025
$329M
Q4 2024
-$103M
Q3 2024
-$12M
Q2 2024
$104M
Q1 2024
$219M
Q4 2023
-$104M
Q3 2023
-$20M
Source: OSCR on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.